ARCHIVES

Herceptin Recommended As Adjuvant For HER2 Positive Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 5 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

In Their Own Words: “Blessed with The Opportunity” vs. “LOWEST Morale Ever”

May 23, 2014

Economic Analyses Of New Therapies Useful In Phase III Studies, Trialists Say

July 24, 2009

Clinical Cancer Research Battling Threats, Frei Says

May 15, 1981

In Brief: House Fills Subcommittee Positions; Senate Schedules NCI Appropriations Hearing Feb. 18

February 13, 1981

In Brief: Oliverio Moves to DEA; Kushner Blass NIH Slow Pay; DeVita Welcomes Hawkin’s Probe

February 6, 1981

Obey Strikes Again, Earmarks NCI Positions

July 2, 1976